Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company's pharmaceuticals operations. The Vaccines segment is dedicated to vaccines and includes the commercial operations of the Company's vaccines division Sanofi Pasteur and dedicated research and development, production and marketing activities for the Company's vaccines operations. Its Rare Diseases products include Cerezyme, Cerdelga, Myozyme and Lumizyme, Fabrazyme, and Aldurazyme. It partners with Alnylam Pharmaceuticals.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolEPA:SAN
CUSIPN/A
Phone+33-1-53774000
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-0.27%
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding Shares1,260,000,000
Sanofi (EPA:SAN) Frequently Asked Questions
What is Sanofi's stock symbol?
Sanofi trades on the EPA under the ticker symbol "SAN."
What price target have analysts set for SAN?
16 Wall Street analysts have issued 12-month price targets for Sanofi's stock. Their forecasts range from €65.00 to €95.00. On average, they anticipate Sanofi's stock price to reach €79.50 in the next year. View Analyst Ratings for Sanofi.
Who are some of Sanofi's key competitors?
Some companies that are related to Sanofi include Total (FP), LVMH (MC), L'Oreal (OR), BNP Paribas (BNP), Airbus (AIR), AXA (CS), Vinci (DG), Kering (KER), Danone (BN), Air Liquide (AI), Schneider Electric (SU), Orange (ORA), Safran (SAF), Soci�t� G�n�rale (GLE), Pernod Ricard (RI), Engie (ENGI), �lectricit� de France (EDF) and Renault (RNO).
Who are Sanofi's key executives?
Sanofi's management team includes the folowing people:
- Serge Weinberg, Independent Chairman of the Board (Age 66)
- Olivier Brandicourt, Chairman of the Executive Committee, Chief Executive Officer, Director (Age 61)
- Jerome Contamine, Executive Vice President, Chief Financial Officer, Member of the Executive Committee (Age 59)
- Karen Marie Linehan, Executive Vice President, Legal Affairs and General Counsel; Member of the Executive Committee (Age 58)
- Olivier Charmeil, Executive Vice President and General Manager, General Medicines & Emerging Markets; Member of the Executive Committee (Age 54)
- Roberto Pucci, Executive Vice President, Human Resources; Member of the Executive Committee (Age 53)
- Dominique Carouge, Executive Vice President - Head of Business Transformation Member of the Executive Committee
- Peter Guenter, Executive Vice President, Diabetes & Cardiovascular; Member of the Executive Committee (Age 55)
- David Loew, Executive Vice President, Sanofi Pasteur; Member of the Executive Committee
- Philippe Luscan, Executive Vice President, Global Industrial Affairs; Member of the Executive Committee (Age 55)
Has Sanofi been receiving favorable news coverage?
Media stories about SAN stock have trended very positive on Thursday, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Sanofi earned a media sentiment score of 0.53 on Accern's scale. They also gave news stories about the company an impact score of 45.22 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
What is Sanofi's stock price today?
One share of SAN stock can currently be purchased for approximately €66.17.
How big of a company is Sanofi?
Sanofi has a market capitalization of $82.98 billion.
How can I contact Sanofi?
Sanofi's mailing address is 54 rue la Boetie, PARIS, 75008, France. The company can be reached via phone at +33-1-53774000.
MarketBeat Community Rating for Sanofi (SAN)
MarketBeat's community ratings are surveys of what our community members think about Sanofi and other stocks. Vote "Outperform" if you believe SAN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SAN will underperform the S&P 500 over the long term. You may vote once every thirty days.
Sanofi (EPA:SAN) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
16 Wall Street analysts have issued ratings and price targets for Sanofi in the last 12 months. Their average twelve-month price target is €79.50The high price target for SAN is €95.00 and the low price target for SAN is €65.00. There are currently 2 sell ratings, 10 hold ratings and 4 buy ratings for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 2.13 | 2.25 | 2.27 | 2.25 |
| Ratings Breakdown: | 2 Sell Rating(s)
10 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
10 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
9 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) | 1 Sell Rating(s)
10 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | €79.50 | €81.19 | €87.47 | €88.56 |
Sanofi (EPA:SAN) Consensus Price Target History
Sanofi (EPA:SAN) Analyst Ratings History
Show:
(Data available from 4/19/2016 forward)
Sanofi (EPA:SAN) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Sanofi (EPA SAN) Insider Trading and Institutional Ownership History
Sanofi (EPA SAN) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Sanofi (EPA SAN) News Headlines
| Source: |
|
Sanofi (EPA:SAN) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Sanofi (EPA SAN) Stock Chart for Thursday, April, 19, 2018
Loading chart…
